Scarica l'app Stockscreener
4.82
2.77%
0.13
Dopo l'orario di chiusura:
4.81
-0.01
-0.21%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$4.69
Aprire:
$4.63
Volume 24 ore:
5.01M
Relative Volume:
1.21
Capitalizzazione di mercato:
$1.14B
Reddito:
$251.85M
Utile/perdita netta:
$-72.58M
Rapporto P/E:
-40.17
EPS:
-0.12
Flusso di cassa netto:
$-63.80M
1 W Prestazione:
-7.66%
1M Prestazione:
-2.03%
6M Prestazione:
-18.17%
1 anno Prestazione:
-18.86%
Intervallo 1D:
$4.58
$4.96
Intervallo di 1 settimana:
$4.32
$5.4695
Portata 52W:
$4.32
$10.13
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Confronta ARDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
4.82 | 1.14B | 251.85M | -72.58M | -63.80M | -0.3134 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Ardelyx: A Small Bet Its Latest Setback Will Be Temporary (NASDAQ:ARDX) - Seeking Alpha
Ardelyx stock hits 52-week low at $4.34 amid market challenges - Investing.com Canada
Ardelyx (NASDAQ:ARDX) Sets New 1-Year LowShould You Sell? - MarketBeat
Ardelyx (NASDAQ:ARDX) Shares Down 6.5%Here's What Happened - MarketBeat
State Street Corp Acquires 176,789 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - The Eastern Progress Online
Ardelyx, Inc. (NASDAQ:ARDX): Is Breakeven Near? - Yahoo Finance
Ardelyx (ARDX) Sees Its Depressed Stock Turning Around - TipRanks
Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - The Eastern Progress Online
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineARDX - The Eastern Progress Online
ARDX LAWSUIT ALERT: The Gross Law Firm Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - The Eastern Progress Online
Ardelyx, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against Ardelyx, Inc - The Eastern Progress Online
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Ardelyx CEO Michael Raab sells $131,620 in stock By Investing.com - Investing.com South Africa
Ardelyx CEO Michael Raab sells $131,620 in stock - Investing.com India
Ardelyx, Inc. (NASDAQ:ARDX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - The Eastern Progress Online
Faruqi & Faruqi Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - The Eastern Progress Online
Objective long/short (ARDX) Report - Stock Traders Daily
Hyperphosphatemia Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Ardelyx, Shield Therapeutics, Kyowa Kirin Co., Ltd., Shanghai Alebund Pharma, Sanofi, Bayer, Keryx - The Globe and Mail
Ardelyx, Inc. (NASDAQ:ARDX): Are Analysts Optimistic? - Simply Wall St
BNP Paribas Financial Markets Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Ardelyx, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsCXM - The Eastern Progress Online
Ardelyx FY2027 EPS Estimate Increased by Leerink Partnrs - MarketBeat
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - The Eastern Progress Online
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ardelyx Inc Azioni (ARDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| RAAB MICHAEL | President & CEO |
Dec 10 '24 |
Sale |
5.26 |
25,000 |
131,620 |
1,150,385 |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):